Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide

Molecular Immunology

Volumn 45, Issue 1, 2008, Pages 226-234

  Rossi, Maria ^a   Ruvo, Menotti ^a   Marasco, Daniela ^a   Colombo, Maurizio ^a   Cassani, Giovanni ^a   Verdoliva, Antonio ^a  

^a Tecnogen SpA   (Italy)

Author keywords

Active cutaneous anaphylaxis; Allergic disorders; IgE; Passive cutaneous anaphylaxis

Indexed keywords

ANTIALLERGIC AGENT; BETA N ACETYLHEXOSAMINIDASE; BINDING PROTEIN; IMMUNOGLOBULIN E; KETOTIFEN; TG 19320; TG19318; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPY; CONTROLLED STUDY; DRUG DOSE INCREASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN VARIANT; RAT; SKIN ANAPHYLAXIS; SURFACE PLASMON RESONANCE;

2,4-DINITROPHENOL; ANIMALS; ANTI-ALLERGIC AGENTS; BIOTINYLATION; HEXOSAMINIDASES; HUMANS; IMMUNOGLOBULIN E; MICE; PASSIVE CUTANEOUS ANAPHYLAXIS; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; SURFACE PLASMON RESONANCE;

RATTUS;

EID: 34548305099     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.04.020     Document Type: Article

References (37)

1. Adkinson N.F., Eggleston P.A., Eney D., Goldstain E.O., Schuberth K.C., Bacon J.R., Hamilton R.G., Weiss M.E., Arshad H., Meinert C.L., Tonascia J., and Wheeler B. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336 (1997) 324-331
2. Alter B.P., Gaston T., and Lipton J.M. Lack of effect of corticosteroids in W/Wv and S1/S1d mice: these strains are not a model for steroid-responsive Diamond-Blackfan anemia. Eur. J. Haematol. 50 (1993) 275-278
3. Barnes P.J., Pedersen S., and Busse W.W. Efficacy and safety of inhaled corticosteroids: an update. Am. J. Respir. Crit. Care Med. 157 (1998) S1-S53
4. Barnes P.J. Therapeutic strategies for allergic diseases. Nature 402 Suppl. (1999) B31-B38
5. Baylink D.J. Glucocorticoid-induced osteoporosis. N. Engl. J. Med. 309 (1983) 306-308
6. Bousquet J., Cabrera P., Berkman N., Buhl R., Holgate S., Wenzel S., Fox H., Hedgecock S., Blogg M., and Della Cioppa G. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60 (2005) 302-308
7. Buku A., Condie B.A., Price J.A., and Mezei M. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors. J. Pept. Res. 66 (2005) 132-137
8. Fassina G., Verdoliva A., Odierna M.R., Ruvo M., and Cassani G. Protein A mimetic peptide ligand for affinity purification of antibodies. J. Mol. Recognit. 9 (1996) 564-569
9. Hoffmann A., Jamin A., Foetisch K., May S., Aulepp H., Haustein D., and Vieths S. Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of β-hexosaminidase release from RBL 2H3 cells. Comparison with classical methods in allergen standardization. Allergy 54 (1999) 446-454
10. Inagaki N., Goro S., Nagai H., and Koda A. Pharmacological characterization of mouse ear PCA. Int. Arch. Allergy Appl. Immunol. 78 (1985) 113-117
11. Inagaki N., Miura T., Nagai H., and Koda A. Active cutaneous anaphylaxis (ACA) in the mouse ear. Jpn. J. Pharmacol. 59 (1992) 201-208
12. Inagaki N., and Nagai H. Drugs for the treatment of allergic diseases. Jpn. J. Pharmacol. 86 (2001) 275-280
13. Joly F., Bessou G., Benveniste J., and Ninio E. Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen. Eur. J. Pharma. 144 (1987) 133-139
14. Kinet J.P., Blank U., Brini A., Jouvin M.H., Kuster H., Mejan O., and Ra C. The high-affinity receptor for immunoglobulin E: a target for therapy of allergic diseases. Int. Arch. Allergy Appl. Immunol. 94 (1991) 51-55
15. Lee E., Choi E.J., Cheong H., Kim Y.-R., Ryu S.Y., and Kim K.-M. Anti-allergic actions of the leaves of Castanea crenata and isolation of an active component responsible for the inhibition of mast cell degranulation. Arch. Pharm. Res. 22 (1999) 320-323
16. Marino M., Ruvo M., De Falco S., and Fassina G. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide. Nat. Biotechnol. 18 (2000) 735-739
17. Marino M., Rossi M., Ruvo M., and Fassina G. Novel molecular targets for systemic lupus erythematosus. Curr. Drug Targets 3 (2002) 223-228
18. Marshall G.D. Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents. J. Allergy Clin. Immunol. 106 (2000) 303-309
19. Meltzer E.O., and Grant J.A. Impact of ceterizine on the burden of allergic rhinitis. Ann. Allergy Asthma Immunol. 83 (1999) 455-463
20. Michaelsen T.E., Ihle Ø., Beckstrøm K.J., Herstad T.K., Kolberg J., Høiby E.A., and Aase A. Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes. Infect. Immun. 71 (2003) 5714-5723
21. Nakamura G.R., Starovasnik A., Reynolds M.E., and Lowman H.B. A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor. Biochemistry 40 (2001) 9828-9835
22. Nakamura G.R., Reynolds M.E., Chen Y.M., Starovasnik M.A., and Lowman H.B. Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1303-1308
23. Ovary Z. Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction. Prog. Allergy 5 (1958) 459-508
24. Palombo G., Rossi M., Cassani G., and Fassina G. Affinity purification of mouse monoclonal IgE using a protein A mimetic ligand (TG19318) immobilized on solid supports. J. Mol. Recognit. 11 (1998) 247-249
25. Palombo G., De Falco S., Tortora M., Cassani G., and Fassina G. A synthetic ligand for IgA affinity purification. J. Mol. Recognit. 11 (1998) 243-246
26. Palombo G., Verdoliva A., and Fassina G. Affinity purification of immunoglobulin M using a novel synthetic ligand. J. Chromatogr. B Biomed. Sci. Appl. 715 (1998) 137-145
27. Piper J.M., Ray W.A., Daugherty J.R., and Griffin M.R. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann. Intern. Med. 114 (1991) 735-740
28. Presta L.G., Lahr S.J., Shields R.L., Porter J.P., Gorman C.M., Fendly B.M., and Jardieu P.M. Humanization of an antibody direct against IgE. J. Immunol. 151 (1993) 2623-2632
29. Rigby L.J., Trist H., Snider J., Hulett M.D., and Hogarth P.M. Monoclonal antibodies and synthetic peptides define the active site of FcepsilonRI and a potential receptor antagonist. Allergy 55 (2000) 609-619
30. Russo A., Russo G., Peticca M., Pietropaolo C., Di Rosa M., and Iuvone T. Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br. J. Pharmacol. 145 (2005) 24-33
31. Till S.J., Francis J.N., Nouri-Aria K., and Durham S.R. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113 (2004) 1025-1034
32. van der Kleij H.P., Kraneveld A., van Houwelingen A.H., Kool M., Weitemberg A.C., Redegeld F.A., and Nijkamp F.P. Murine model for non-IgE-mediated asthma. Inflammation 28 (2004) 115-125
33. Verdoliva A., Basile G., and Fassina G. Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand. J. Chromatogr. B 749 (2000) 233-242
34. Verdoliva A., Pannone F., Rossi M., Catello S., and Manfredi V. Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: comparison with protein A and protein G. J. Immunol. Methods 271 (2002) 77-88
35. Wiegand T.W., Williams P.B., Dreskin S.C., Jouvin M.H., Kinet J.P., and Tasset D. High-affinity oligonucleotide ligands to human IgE Inhibit binding to Fcε Receptor I. J. Immunol. 157 (1996) 221-230
36. Yamanishi R., Kondo K., Tsuji H., and Ogawa T. Micro-assay to Measure the allergenicity of Kunitz-type Soybean Trypsin Inhibitor toward Balb/c Mice by Using RBL-2H3 Cells. Biosci. Biotech. Biochem. 59 (1995) 1272-1275
37. Yan H., Lamm M.E., Björling E., and Huang Y.T. Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J. Virol. 76 (2002) 10972-10979